Delhi High Court Awards Rs.3.34 Crore to Johnson & Johnson in Counterfeit Medical Products Case

The Delhi High Court awarded Rs. 3.34 Crore to Johnson & Johnson for trademark infringement and counterfeiting of its medical products.

The court noted that the defendants’ actions harmed public health and J&J’s goodwill and market reputation.

The 2019 lawsuit accused them of producing, distributing and selling fake surgical products under trademarks like SURGICEL, ETHICON, and LIGACLIP. 

Justice Amit Bansal found the infringement deliberate, conscious and willful.

The court ordered Rs. 2.34 Crore in compensatory damages, Rs. 1 Crore in exemplary damages, and issued a permanent injunction stopping the defendants from using J&J’s trademarks.